Longmu Medical
长木谷医疗
Longmu Medical (长木谷医疗) is a Beijing-based artificial intelligence healthcare company focused on disease imaging diagnosis and precision surgical assistance, founded by a core team with roots at Harvard Medical School's Longwood Medical Area and Stanford University's Silicon Valley hub. The company closed a seed round of tens of millions of RMB in late 2018, co-invested by FreeS Fund and Lei Ming, one of Baidu's seven co-founders. FreeS Fund, which counts Longmu Medical among its early portfolio companies, has continued to reference it alongside other notable investments such as Universal Robots and AUBO as examples of its healthcare and robotics track record. Elsewhere's corpus does not contain more recent updates on the company's development beyond this 2018-2019 period.
AI-generated — may contain errors, please verify.
Coverage
How Far Is Embodied Intelligence from Reality: Hype, Bubble, Technological Frontier, and Commercialization | FreeS Research --- In 2024, embodied intelligence remains one of the most watched tracks in the tech investment landscape. From humanoid robots to intelligent robotic arms, from autonomous driving to smart prosthetics — the concept of "embodied intelligence" seems to be everywhere. Yet when we peel back the layers of buzzwords, a fundamental question persists: **How far is this technology actually from real-world application?** ## The Hype Cycle: Where Are We Now? The current wave of embodied intelligence enthusiasm bears the classic hallmarks of a technology hype cycle. Capital is pouring in, media coverage is frenzied, and demos are increasingly spectacular. But history offers cautionary parallels. Consider the trajectory of autonomous driving. A decade ago, full self-driving was touted as "just around the corner." Today, while significant progress has been made, true L5 autonomy remains elusive. The gap between laboratory demonstration and scalable, reliable deployment proved far wider than anticipated. Embodied intelligence faces an analogous challenge. A robot performing a backflip or making coffee in a controlled environment is not the same as one that can operate robustly across unpredictable real-world conditions. ## The Bubble Question:
AI veers left, robotics veers right, and embodied intelligence stands at the intersection.
FreeS Fund received eight recognitions from institutions including *Fortune* (Chinese edition), 36Kr, and the Fund of Funds Alliance.
Do what's right, not what's easy.
Our Past 100 Days: Sailing Against the Wind, Growing Toward the Sun
Venture Capital's Pandemic Fight: A Chronicle
Two joyous gatherings, spotlighted by *People's Daily* commentary, Forbes China's Best Venture Capitalist, and 50+ other awards... The past is prologue; the future holds promise.
Do what's right, not what's easy.
FreeS Fund Lands on 36Kr's "Top 10 Dark Horse Funds in China," Hard Tech Bets Earn LP Recognition
Do what's right, not what's easy.
FreeS Fund Wins Three Awards at ChinaVenture's 2018 Annual Rankings
Do what is right, not what is easy.
We Want You! FreeS Fund 2019 Spring North America Roadshow
You're the next star-picker in venture capital.
FreeS Fund Is Hiring Investors | Let's Do What's Right, Not What's Easy
"The Summit" is rising — we're waiting for you!
Breaking Through Technical Bottlenecks, Surpassing 20 Million Followers... 16 Takeaways and 5 Insights | FreeS Fund Blackboard · November
Continue doubling down on consumer and deep tech.
Changmugu Medical Closes Tens of Millions of RMB Seed Round | FreeS Fund Investment News
Build world-class AI healthcare products.
